Literature DB >> 23984954

Matrix-M adjuvant: enhancing immune responses by 'setting the stage' for the antigen.

Karin Lövgren Bengtsson, Karin H Karlsson, Sofia E Magnusson, Jenny M Reimer, Linda Stertman.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23984954     DOI： 10.1586/14760584.2013.814822

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  15 in total

1.  Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants.

Authors:  Robyn Marty-Roix; Gregory I Vladimer; Kimberly Pouliot; Dan Weng; Rachel Buglione-Corbett; Kim West; John D MacMicking; Jonathan D Chee; Shixia Wang; Shan Lu; Egil Lien
Journal:  J Biol Chem       Date:  2015-11-10       Impact factor: 5.157

2.  Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice.

Authors:  Katharine A Collins; Florian Brod; Rebecca Snaith; Marta Ulaszewska; Rhea J Longley; Ahmed M Salman; Sarah C Gilbert; Alexandra J Spencer; David Franco; W Ripley Ballou; Adrian V S Hill
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

3.  Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.

Authors:  Mehreen S Datoo; Magloire H Natama; Athanase Somé; Ousmane Traoré; Toussaint Rouamba; Duncan Bellamy; Prisca Yameogo; Daniel Valia; Moubarak Tegneri; Florence Ouedraogo; Rachidatou Soma; Seydou Sawadogo; Faizatou Sorgho; Karim Derra; Eli Rouamba; Benedict Orindi; Fernando Ramos Lopez; Amy Flaxman; Federica Cappuccini; Reshma Kailath; Sean Elias; Ekta Mukhopadhyay; Andres Noe; Matthew Cairns; Alison Lawrie; Rachel Roberts; Innocent Valéa; Hermann Sorgho; Nicola Williams; Gregory Glenn; Louis Fries; Jenny Reimer; Katie J Ewer; Umesh Shaligram; Adrian V S Hill; Halidou Tinto
Journal:  Lancet       Date:  2021-05-05       Impact factor: 202.731

4.  Vaccine-induced protection of rhesus macaques against plasma viremia after intradermal infection with a European lineage 1 strain of West Nile virus.

Authors:  Babs E Verstrepen; Herman Oostermeijer; Zahra Fagrouch; Melanie van Heteren; Henk Niphuis; Tom Haaksma; Ivanela Kondova; Willy M Bogers; Marina de Filette; Niek Sanders; Linda Stertman; Sofia Magnusson; Orsolya Lőrincz; Julianna Lisziewicz; Luisa Barzon; Giorgio Palù; Michael S Diamond; Stefan Chabierski; Sebastian Ulbert; Ernst J Verschoor
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

5.  Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines.

Authors:  David J Gasper; Brandon Neldner; Erin H Plisch; Hani Rustom; Emily Carrow; Hirotaka Imai; Yoshihiro Kawaoka; M Suresh
Journal:  PLoS Pathog       Date:  2016-12-20       Impact factor: 6.823

6.  Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models.

Authors:  Ahmed M Salman; Eduardo Montoya-Díaz; Heather West; Amar Lall; Erwan Atcheson; Cesar Lopez-Camacho; Jai Ramesar; Karolis Bauza; Katharine A Collins; Florian Brod; Fernando Reis; Leontios Pappas; Lilia González-Cerón; Chris J Janse; Adrian V S Hill; Shahid M Khan; Arturo Reyes-Sandoval
Journal:  Sci Rep       Date:  2017-04-18       Impact factor: 4.379

7.  Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine.

Authors:  Eduardo Alves; Ahmed M Salman; Fabiana Leoratti; Cesar Lopez-Camacho; Martha Eva Viveros-Sandoval; Amar Lall; Aadil El-Turabi; Martin F Bachmann; Adrian V S Hill; Chris J Janse; Shahid M Khan; Arturo Reyes-Sandoval
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

8.  Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice.

Authors:  Sofia E Magnusson; Arwen F Altenburg; Karin Lövgren Bengtsson; Fons Bosman; Rory D de Vries; Guus F Rimmelzwaan; Linda Stertman
Journal:  Immunol Res       Date:  2018-04       Impact factor: 2.829

9.  Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine.

Authors:  Freek Cox; Eirikur Saeland; Matthijs Baart; Martin Koldijk; Jeroen Tolboom; Liesbeth Dekking; Wouter Koudstaal; Karin Lövgren Bengtsson; Jaap Goudsmit; Katarina Radošević
Journal:  Virol J       Date:  2015-12-08       Impact factor: 4.099

10.  Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability.

Authors:  Emilia Bigaeva; Eva van Doorn; Heng Liu; Eelko Hak
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.